ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $139 | -12.6% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $159 | -74.5% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $623 | -37.7% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $5,000 | -16.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $5,000 | -28.6% | 100 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |